PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Dalteparin sodium - Pre-operative / bridging therapy

PAD Profile : Dalteparin sodium - Pre-operative / bridging therapy

Keywords :
Low Molecular Weight Heparins, LMWH
Brand Names Include :
Fragmin

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
28 April 2010
Not Set
The committee were informed that pre-operative LMWH is included within the PbR tariff and should therefore be prescribed/provided by the acute trusts. It should be noted that private patients should not receive care that is different to that of NHS patients and on that principle, the pre-operative LMWH should form part of that patients' private care

Associated BNF Codes

02. Cardiovascular System
02.08.01. Parenteral anticoagulants
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More